LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Island Setting Receives Improved Clinical Laboratory Diagnostics

By LabMedica International staff writers
Posted on 13 Jul 2009
A testing system is helping to improve efficiency in a hospital laboratory on the Isle of Guernsey.

The new system benefits both staff and patients. Previously, different platforms meant multiple blood draws--one serum tube for each of the analyzers, usually three to four per patient-to obtain results as quickly as possible. The new workflow makes the phlebotomist's work easier and means less discomfort for the patient.

Two cobas 6000 analyzers linked to modular preanalytics from Roche (Burgess Hill, UK) are helping the laboratory at Princess Elizabeth Hospital (St Martins, Guernsey BCD) increase efficiency and become more self-sufficient.

"Although [we are] a small isolated lab, we try to do as much as possible ourselves. We were dealing with an escalating number of tests and when the time came to upgrade four aging analyzers in our clinical chemistry department, consolidation seemed an obvious solution," explained Nigel Turner, section head of clinical chemistry at the hospital. With 183 different assays, Roche offers tests on an automated serum work area (SWA) platform, thus providing an ideal solution for the Guernsey laboratory.

As the lab runs a multidisciplinary on-call system, people from various fields including hematology or histology are also required to run the analyzers outside normal core hours. Now, it is just one blood tube, one analyzer.

Roche Diagnostics helps health professionals detect, monitor, and manage the patient's medical condition more effectively.


Related Links:
Roche
Princess Elizabeth Hospital


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Silver Member
PCR Plates
Diamond Shell PCR Plates
Capillary Blood Collection Tube
IMPROMINI M3

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more